Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CT-2103 in Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
NCT00017017Phase 2Completed
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Start
- Feb 2001
- Primary completion
- Feb 2003
- Modality
- Polymer-based Nanoparticles, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of paclitaxel poliglumex in ovarian epithelial carcinoma, fallopian tube carcinoma (PFTC), primary peritoneal carcinoma (PPC), sponsored by Memorial Sloan Kettering Cancer Center. Started Feb 2001; status: completed.
02
Drugs
paclitaxel poliglumex
03
Conditions
ovarian epithelial carcinomafallopian tube carcinoma (PFTC)primary peritoneal carcinoma (PPC)
Beyond the preview
Go deeper on NCT00017017.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00017017.